Introducing License to Cure for BioPharma – Industry Solution Experience

Dassault Systèmes License to Cure for BioPharma provides a connected and comprehensive regulatory and quality platform to accelerate therapeutic approval, production and patient adoption in a global landscape.

Download this 15 minute webinar where Compliance Consultant, Warren Perry, GRCP, covers:

  • The latest trends and challenges facing the pharmaceutical and biotech industries 
  • How the License to Cure for BioPharma can address those challenges
  • Examples of organizations that have used the capabilities of License to Cure and the benefits they have gained
To find out more about License to Cure for BioPharma please fill out the form to complete your request. And download the solution brief to learn even more about the capabilities and benefits . 

Please complete the form to register and immediately view this webinar.

Accelerate Therapeutic Approval and Production in a Global Landscape